SNSW released its semi-annual performance report, with a net profit attributable to the parent company of 88.96 million yuan, a year-on-year increase of 308.29%

SNSW released its semi-annual report for 2025, with revenue of 338 million yuan, a year-on-year increase of 69.69%; net profit attributable to the parent company of 88.96 million yuan, a year-on-year increase of 308.29%; net profit excluding non-recurring gains and losses of 89.48 million yuan, a year-on-year increase of 367.92%; basic earnings per share of 0.57 yuan. The significant increase in net profit is mainly due to the increase in sales of active pharmaceutical ingredients, a decrease in R&D expenses, and a reduction in market business expenses